drugset / Trial / NCT03278925
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis
NaSingle-groupOpen-labelPrevention
Summary
This phase I trial studies the side effects and best dose of defined green tea catechin extract and to see how well it works in preventing liver cancer in participants with cirrhosis. Higher levels of the molecule gamma-OHPdG may be found in participants with cirrhosis, which may mean a higher risk of the development of liver cancer. Defined green tea catechin extract may work better to lower levels of gamma-OHPdG and prevent the development of liver cancer.
Timeline
- Start
- 2018-08-09
- Primary completion
- 2023-06-16
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epigallocatechin gallate | Small molecule | — | Oral |